Rangering i aksjer
#29600
Ulisse Biomed S.p.A. is an Italy-based biotechnology enterprise specializing in... Ulisse Biomed S.p.A. is an Italy-based biotechnology enterprise specializing in healthcare diagnostics. The company develops and markets a diverse range of innovative platforms and products designed for disease detection. Central to its offerings is the Sagitta platform, which encompasses specialized tests such as Ladymed/HPV Selfy for human papillomavirus screening, CoronaMelt for identifying SARS-CoV-2, and CoronaMelt Var for detecting and genotyping SARS-CoV-2 variants. Sagitta also provides UlisseFaster, a vital reagent used for the pre-treatment of biological samples, alongside various diagnostic tools for sexually transmitted infections and for detecting HPV associated with oropharyngeal cancers. Beyond Sagitta, Ulisse Biomed boasts the NanoHybrid platform, an advanced multi-modal biomolecule system that utilizes DNA/PNA technology to directly identify specific antibodies and protein analytes from serum or whole blood samples. Its portfolio is further enhanced by the Aptavir platform, dedicated to the development and manufacturing of synthetic nucleic acid molecules aimed at curtailing the infectiousness of pathogens. Established in 2015, Ulisse Biomed S.p.A. operates from its headquarters in Udine, Italy.
Aksjekurs
$0.93739396
Sist synkronisert: 2026-01-08
Handel Ulisse Biomed S.p.A. (UBM)
Pris UBM pris med markedsverdi på B
Markedsverdi av Ulisse Biomed S.p.A.(UBM)
Markedsverdi: $20.44M
Per August 2026 har Ulisse Biomed S.p.A. en markedsverdi på $20.44M. Dette gjør Ulisse Biomed S.p.A. til det 29600th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Ulisse Biomed S.p.A. fra 2021 til 2026
UBM sammenlignet med topp 5 mest populære stocks
| Pris på UBM |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.307T
|
+25,962,013.18%
|
|
|
|
|
$4.551T
|
+22,264,070.89%
|
|
|
|
|
$4.154T
|
+20,324,863.37%
|
|
|
|
|
$3.589T
|
+17,556,640.26%
|
|
|
|
|
$2.797T
|
+13,683,298.50%
|
